ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,544Medicare Part D Prescriptions Filled, Including Refills

Rank: 33 out of 336

$1.14M Total Retail Price of All Prescriptions

Rank: 25 out of 336

620 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 620 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

19% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 17,243 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
SIMVASTATIN 1,347 1,181 1 5
OMEPRAZOLE 948 838 2 3
AMLODIPINE BESYLATE 584 527 3 1
LEVOTHYROXINE SODIUM 580 551 4 7
GLIMEPIRIDE 522 441 5 29
LOSARTAN POTASSIUM 486 453 6 22
FUROSEMIDE 447 387 7 4
HYDROCODONE-ACETAMINOPHEN 369 273 S3 8 2
CARVEDILOL 361 308 9 13
CITALOPRAM HBR 358 350 10 21
CRESTOR 354 284 11 25
SPIRONOLACTONE 347 291 12 42
POTASSIUM CHLORIDE 339 267 13 9
GABAPENTIN 338 274 14 11
LISINOPRIL 328 232 15 6
ALLOPURINOL 318 272 16 30
MELOXICAM 297 239 17 19
DONEPEZIL HCL 289 282 18 27
RANITIDINE HCL 288 252 19 36
ATENOLOL 279 228 20 26
METFORMIN HCL ER 271 253 21 61
DIOVAN 261 215 22 31
BUPROPION XL 214 199 23 209
ATORVASTATIN CALCIUM 212 168 24 14
TAMSULOSIN HCL 205 180 25 38
CYMBALTA 201 187 26 52
BYSTOLIC 197 154 27 79
WARFARIN SODIUM 195 177 28 17
JANUMET 194 139 29 134
TIZANIDINE HCL 182 107 30 83
CHLORTHALIDONE 179 142 31 111
CLOPIDOGREL 176 166 32 28
TRAMADOL HCL 171 116 33 20
JANUVIA 166 136 34 67
AMLODIPINE BESYLATE-BENAZEPRIL 166 134 34 47
PRAVASTATIN SODIUM 165 149 36 10
ISOSORBIDE MONONITRATE ER 160 147 37 44
EXFORGE 147 110 38 121
NEXIUM 133 88 39 24
CLONIDINE HCL 132 105 40 32
INDAPAMIDE 130 84 41 160
DOXYCYCLINE HYCLATE 127 107 42 92
FAMOTIDINE 124 112 43 73
ACTOS 120 114 44 119
ZALEPLON 119 84 10 45 263
METOPROLOL TARTRATE 117 113 46 16
ACETAMINOPHEN-CODEINE 114 88 S3 47 136
KLOR-CON M20 114 83 47 51
KOMBIGLYZE XR 113 83 49 268
VENLAFAXINE HCL ER 112 73 50 100
LABETALOL HCL 107 79 51 194
NIZATIDINE 105 100 52 291
PLAVIX 105 102 52 37
SYNTHROID 104 80 54 43
LOSARTAN-HYDROCHLOROTHIAZIDE 101 85 55 45
NAMENDA 100 100 56 39
KLOR-CON 10 99 91 57 75
PREDNISONE 98 79 58 48
LYRICA 87 53 59 70
DIGOXIN 84 80 60 50
METOPROLOL SUCCINATE 83 61 61 15
MUPIROCIN 81 69 62 203
LOVAZA 80 46 63 157
FLUTICASONE PROPIONATE 80 72 63 49
NATEGLINIDE 78 60 65 300
QUETIAPINE FUMARATE 77 65 66 94
MECLIZINE HCL 77 77 66 96
ONGLYZA 73 48 68 165
PANTOPRAZOLE SODIUM 68 64 69 40
SINGULAIR 67 64 70 85
DILTIAZEM ER 67 51 70 138
CIPROFLOXACIN HCL 66 57 72 55
METFORMIN HCL 66 52 72 8
DOXAZOSIN MESYLATE 65 48 74 86
IRBESARTAN 63 54 75 213
COLCRYS 63 48 75 103
ESCITALOPRAM OXALATE 62 43 77 69
DILTIAZEM 24HR CD 60 47 78 126
BUPROPION HCL SR 57 33 79 199
MIRTAZAPINE 57 35 79 66
BENICAR HCT 56 56 81 132
BENICAR 56 56 81 112
SERTRALINE HCL 51 51 83 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.